Dr. Ruth Westheimer is America’s most renowned sex expert. She shares her decades of experience answering questions on sex. What are the most common concerns facing couples? The husband and wife team of Irwin and Sue Goldstein have blazed a trail for recognizing sexual medicine as a specialty. They share secrets about female sexual dysfunction and reveal some surprising new research about drug development for women. Pink Viagra may not be a pipe dream. Guests: Dr. Ruth Westheimer is America’s best known sex expert. She has degrees in sociology and a doctorate in education from Columbia University. She completed post-doctoral work in human sexuality at New York Presbyterian. She hosted a radio show on WYNY called "Sexually Speaking" for many years. Some of her books include: Sex for Dummies Rekindling Romance for Dummies Dr. Ruth’s Guide to Safer Sex Sex and Morality: Who is Teaching our Sex Standards? Dr. Ruth’s Guide to Good Sex Sex After 50: Revving Up the Romance, Passion and Excitement Her Web site is www.drruth.com Irwin Goldstein, MD, is editor-in-chief of The Journal of Sexual Medicine and Director of Sexual Medicine at Alvarado Hospital in San Diego, California. He is also Clinical Professor of Surgery at University of California at San Diego and Director of San Diego Sexual Medicine. Sue Goldstein is sexual medicine education coordinator and co-author of the book, When Sex Isn’t Good: Stories and Solutions of Women with Sexual Dysfunction.
Click here to download our podcast.

Join Over 53,000 Subscribers at The People's Pharmacy

Each week we send two free email newsletters with breaking health news, prescription drug information, home remedies and a preview of our award-winning radio show. Join our mailing list and get the information you need to make confident choices about your health.

  1. wh
    Reply

    I know there was a discussion about Chnatix for PSAS on the program by DR. Goldstein. With the below announcement that was on the news, is he still using this drug on women off label, or what is he advising them to do?
    Trucking regulators warn against Chantix
    Published: May 23, 2008 at 12:54 PM
    Print story Email to a friend Font size:WASHINGTON, May 23 (UPI) — U.S. federal trucking regulators have advised medical examiners not to qualify anyone using Chantix, an anti-smoking drug linked to possible health issues.
    The Federal Motor Carrier Safety Administration is the latest regulator to warn against certifying people using the smoking cessation aid. The Federal Administration banned the drug for pilots and air traffic controllers after a study linked Chantix to seizures, dizziness, heart irregularities and diabetes.
    In its warning issued Thursday the FMCSA advised medical examiners “to not qualify anyone currently using this medication for commercial motor vehicle licenses,” The Wall Street Journal reported Friday. The FMCSA oversees the interstate trucking and bus industry.
    A U.S. Food and Drug Administration spokeswoman said the agency was focusing on likely links between Chantix and neuropsychiatric side effects. This year, the FDA and Pfizer, which manufactures the drug, updated warnings on Chantix’s label to include depression and thoughts of suicide.
    The Institute for Safe Medication Practices, a non-profit watchdog group in Horsham, Pa., conducted the Chantix study that reported the drug was linked to more than 900 serious episodes in the last quarter of 2007.
    Pfizer said the report’s findings weren’t inconsistent with possible side effects listed on drug’s label.

What Do You Think?

Share your thoughts with others, but be mindful of protecting your own and others' privacy. Not all comments will be posted. Advice from web visitors is not a substitute for medical attention. Do not stop any medicine without checking with the prescriber. In posting a comment, you agree to our commenting policy and website terms and conditions.